Evidence map›Paper›PMID 39563601›Full record

ArticlePharmacogenomics2024

Advancing pharmacogenomics research: automated extraction of insights from PubMed using SpaCy NLP framework.

Esther Camilo Dos Reis, Santiago Caneppa, Pedro Vasconcelos, Paulo Caleb Júnior de Lima Santos

Abstract read
In one paragraph

Article in Pharmacogenomics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Esther Camilo Dos ReisINFAR - Instituto de Farmacologia e Biologia Molecular, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brasil.
Santiago CaneppaResearch and Development Area, Gntech Exames, Florianópolis, Santa Catarina, Brazil.
Pedro VasconcelosINFAR - Instituto de Farmacologia e Biologia Molecular, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brasil.
Paulo Caleb Júnior de Lima SantosINFAR - Instituto de Farmacologia e Biologia Molecular, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brasil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper presents a methodology for automatically extracting insights from PubMed articles using a Natural Language Processing (NLP) framework. Our approach, leveraging advanced NLP techniques and Named Entity Recognition (NER), is crucial for advancing pharmacogenomics and other scientific fields that benefit from streamlined access to literature through automated services like RESTful APIs.Building a new NLP model presents several challenges. First, it is essential to have a thorough understanding of the field in order to define relevant entities. Second, the construction of a diverse and consistent set of examples is crucial. Finally, the effective utilization of pre-established models is of paramount importance, as demonstrated in this work.Our model, validated via ten-fold cross-validation, achieved over 70% recall and precision for all entities in the training set. We provide a reproducible pipeline for the scientific community and propose a structured approach for qualitative analysis and clustering of results. This methodology refines literature reviews, optimizes knowledge extraction, and supports broader application across diverse research domains. An online platform could further extend these benefits to researchers, educators, and practitioners.

Indexed as

Natural Language ProcessingPharmacogeneticsPubMedData MiningHumansE-utilitiesnamed entity e-utilities recognition (NER)NLP (natural language processing)Pharmacogenomicsscientific literature miningSpaCy

Identifiers

PMID39563601
PMCPMC11703043

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.